Price $66.33 |
Market Cap
290M
|
Sector Health Care |
Div. Growth
2.20%
|
|
P/E
17.1
|
P/B
2.41
|
P/S
5.65
|
Dividend %
1.50%
|
|
P/CF
16.0
|
P/FCF
16.2
|
Op. Cash Flow
23.1K
|
FCF
4.9
|
|
Op. Margin
36.80%
|
Net Margin
33.20%
|
ROE
14.90%
|
ROI
13.70%
|
|
ROA
13.80%
|
EPS Growth
8.70%
|
Current Ratio
15.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
